miR-191 also displayed tumor-type specific roles in tumorigenesis, as miR-191 represses MDM4 and CDK6 expression in ovarian and thyroid follicular cancer, thereby delaying cancer progression and tumor-related death [25,26]. This evidence concerns the gene MDM4 and neoplasm.